Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small-dose esketamine pretreatment for prevention of sufentanil-induced cough during induction of general anesthesia
ChiCTR2200061894Phase 4Not yet recruiting
- Sponsor
- Air Force Medical Center, PLA
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (2 arms), sponsored by Air Force Medical Center, PLA. Primary endpoints: Cough times within 1 minute after sufentanil administration, Mean arterial pressure (MAP) and 1 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2200061894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061894.